Form 4: Health In Tech CGO Granted 200K Restricted Shares

Health In Tech's Chief Growth Officer, Zain Syed Hasan, was granted 200,000 restricted Class A Common Stock shares tied to future company transactions.

Summary

• Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc. (HIT), was granted 200,000 shares of Class A Common Stock on January 6, 2026.
• These shares are restricted and granted under the Health in Tech Equity Incentive Plan.
• The grant is contingent on the closing of two proposed issuer transactions.
• Half of the shares (100,000) will vest in equal monthly installments over 12 months, starting upon the closing of the first transaction.
• The other half of the shares (100,000) will vest in equal monthly installments over 12 months, starting upon the closing of the second transaction.
• Vesting is subject to continued service by Mr. Hasan.
• If either proposed transaction does not close within 24 months after January 6, 2026, the unvested shares related to that specific transaction will be automatically forfeited without consideration.
• Following this transaction, Mr. Hasan beneficially owns 220,000 shares of Class A Common Stock, which includes these 200,000 restricted shares.

Sentiment

Score: 7

Explanation: The grant of restricted stock aligns the Chief Growth Officer's incentives with the company's strategic growth and successful completion of future transactions, which is generally positive for long-term value creation, though the conditional vesting introduces some uncertainty.

Positives

• The grant of restricted shares aligns the Chief Growth Officer's incentives with the company's strategic objectives and the successful completion of future transactions.
• Equity incentives are a standard mechanism for executive retention and motivation, potentially fostering long-term value creation for shareholders.

Risks

• The forfeiture clause for unvested shares if the proposed transactions do not close within 24 months introduces uncertainty regarding the full realization of the grant.
• The success of the vesting schedule is directly tied to the successful execution and closing of two future, unspecified issuer transactions, which may not materialize as planned.

Future Outlook

The grant of restricted shares is explicitly tied to the successful closing of two proposed issuer transactions, indicating potential strategic developments or acquisitions for Health In Tech in the near future. The vesting schedule incentivizes the Chief Growth Officer to contribute to these strategic successes.

Industry Context

The use of restricted stock grants as a form of executive compensation is a common practice in the technology and healthcare sectors, particularly for growth-oriented companies. It serves to align the interests of key management personnel with long-term shareholder value creation and strategic objectives.

Comparison to Industry Standards

• The grant of restricted stock is a common executive compensation mechanism used across various industries to align management incentives with long-term shareholder value.
• The specific terms, such as vesting over 12 months tied to transaction closings, are typical for performance-based equity awards.
• The filing does not provide specific comparable companies, projects, or results for a direct benchmark against industry standards.

Corporate Governance

Related Party Transactions

• The grant of 200,000 restricted shares to Chief Growth Officer Zain Syed Hasan constitutes a transaction with a related party (an executive officer) as part of his compensation package.

Stakeholder Impact

• Shareholders: Potential positive impact through enhanced management alignment with strategic growth and long-term value creation.
• Employees (Chief Growth Officer): Direct benefit through equity compensation, subject to performance and transaction milestones, providing a strong incentive for continued service and success.

Next Steps

• Closing of the first proposed issuer transaction, triggering the start of vesting for 100,000 shares.
• Closing of the second proposed issuer transaction, triggering the start of vesting for another 100,000 shares.
• Continued service by Zain Syed Hasan to ensure vesting of shares.
• Monitoring the 24-month deadline for transaction closings to avoid forfeiture of unvested shares.

Key Dates

Recommendation

The grant of restricted stock to a key executive aligns their interests with the company's strategic objectives and future growth, which is a positive signal for long-term value. However, this single event does not provide enough information to change a broader investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Health In Tech, HIT, Form 4, SEC filing, restricted stock, equity incentive plan, Chief Growth Officer, Zain Syed Hasan, stock grant, executive compensation, corporate governance